Skip to content
10-Q

Quarterly Report

EVOKE PHARMA, INC.

0000950170-25-108407

← back to feed
Filed
Aug 14, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 1.56M sh
Shares Diluted Q2 2025 · Jun 30, 2025 2.55M sh
Shares Diluted Q2 2025 · Jun 30, 2025 2.55M sh
Shares Diluted Q2 2025 · Jun 30, 2024 1.36M sh
Shares Diluted Q2 2025 · Jun 30, 2024 1.06M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$1.56M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$3.4M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $12.06M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $13.6M
Stockholders Equity Q2 2025 · Jun 30, 2025 $4.37M
Stockholders Equity Q2 2025 · Mar 31, 2025 $5.84M
Stockholders Equity Q2 2025 · Dec 31, 2024 $7.04M
Stockholders Equity Q2 2025 · Jun 30, 2024 $2.66M
Stockholders Equity Q2 2025 · Mar 31, 2024 $3.5M
Stockholders Equity Q2 2025 · Dec 31, 2023 −$2.58M
Current Liabilities Q2 2025 · Jun 30, 2025 $11.62M
Current Liabilities Q2 2025 · Dec 31, 2024 $10.38M
Total Liabilities Q2 2025 · Jun 30, 2025 $11.69M
Total Liabilities Q2 2025 · Dec 31, 2024 $10.48M
Current Assets Q2 2025 · Jun 30, 2025 $15.93M
Current Assets Q2 2025 · Dec 31, 2024 $17.24M
Total Assets Q2 2025 · Jun 30, 2025 $16.06M
Total Assets Q2 2025 · Dec 31, 2024 $17.52M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.62
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.13
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.93
Eps Diluted Q2 2025 · Jun 30, 2024 −$2.69
Eps Basic Q2 2025 · Jun 30, 2025 −$0.62
Eps Basic Q2 2025 · Jun 30, 2025 −$1.13
Eps Basic Q2 2025 · Jun 30, 2024 −$0.93
Eps Basic Q2 2025 · Jun 30, 2024 −$2.69
Sga Expense Q2 2025 · Jun 30, 2025 $5.13M
Sga Expense Q2 2025 · Jun 30, 2025 $9.43M
Sga Expense Q2 2025 · Jun 30, 2024 $3.73M
Sga Expense Q2 2025 · Jun 30, 2024 $6.87M
Net Income Q2 2025 · Jun 30, 2025 −$1.57M
Net Income Q2 2025 · Jun 30, 2025 −$2.88M
Net Income Q2 2025 · Mar 31, 2025 −$1.31M
Net Income Q2 2025 · Jun 30, 2024 −$1.27M
Net Income Q2 2025 · Jun 30, 2024 −$2.85M
Net Income Q2 2025 · Mar 31, 2024 −$1.58M
Operating Income Q2 2025 · Jun 30, 2025 −$1.56M
Operating Income Q2 2025 · Jun 30, 2025 −$2.86M
Operating Income Q2 2025 · Jun 30, 2024 −$1.22M
Operating Income Q2 2025 · Jun 30, 2024 −$2.72M
Revenue Q2 2025 · Jun 30, 2025 $3.75M
Revenue Q2 2025 · Jun 30, 2025 $6.83M
Revenue Q2 2025 · Jun 30, 2024 $2.55M
Revenue Q2 2025 · Jun 30, 2024 $4.29M